✦ LIBER ✦

PND26 Estimated Costs of First-Year Monitoring and Administration of Multiple Sclerosis Therapies in the United States

✍ Scribed by H.C. Trautman; J.A. Clark; H. Huleatt; M. Oleen-Burkey; C. Brewster

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND8 Prevalence and Incidence Rates of M

✍ Baser, O.; Wang, L.; Li, T.; Shu, Z.; Xie, L. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND72 Access, Uptake and Utilization Man

✍ Aggarwal, S. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND61 Impact of Patient Cost-Sharing Arr

✍ L.A. Palmer; R. Fowler; N. Shi; H. Dastani; S. Abouzaid; E. Kim 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PRS28 COST-UTILITY ANALYSES OF DISEASE-M

✍ M Yang; WW Tseng; SS Sansgiry 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB9 IMPACT OF EXENATIDE, PEN INSULIN AN

✍ N. Rashid; J. McCombs; S. Foster; L.A. Miller 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Incidence, Prevalence, Costs, and Impact

✍ Ma, Vincent Y.; Chan, Leighton; Carruthers, Kadir J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 494 KB